This federal contract award, valued at $3,074.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that the company holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the provision of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting, to support military healthcare programs. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen's extensive experience and capabilities in the distribution of a wide range of pharmaceutical products and medical supplies to federal government agencies, particularly the military, make it a key vendor for these types of contracts.
Generated 4/1/25, 3:44 PM